Last reviewed 2026-04-20 · How we verify

THENIUM CLOSYLATE

FDA-approved active Small molecule Quality 6/100

THENIUM CLOSYLATE is a drug. It is currently FDA-approved.

At a glance

Generic name	THENIUM CLOSYLATE
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

THENIUM CLOSYLATE CI brief — competitive landscape report
THENIUM CLOSYLATE updates RSS · CI watch RSS

Frequently asked questions about THENIUM CLOSYLATE

What is THENIUM CLOSYLATE?

THENIUM CLOSYLATE is a Small molecule drug.

What development phase is THENIUM CLOSYLATE in?

THENIUM CLOSYLATE is FDA-approved (marketed).

Therapeutic area: All drugs in Other